Beginning Saturday, April 1, all practitioners who prescribe controlled substances will be required to use the Wisconsin enhanced Prescription Drug Monitoring Program (WI ePDMP). This latest requirement comes from 2015 Act 266, which is a piece of the Heroin, Opioid, Prevention and Education (HOPE) Agenda.

“This new requirement is imperative in ensuring that we continue to prevent opioid abuse,” said Governor Walker. “We have made great strides thus far, and the implementation of this legislation will continue to help us fight the misuse, abuse, and diversion of controlled prescription drugs.”

While some practitioners have voluntarily been using the system since its inception in 2013, law did not require them to do so.

Follow Prescription Advisory

What prescribers can do to safely and effectively use opioids for CNCP (includes the following)

  • Screen for prior or current substance abuse/misuse
  • Do not use concomitant sedative–hypnotics or benzodiazepines
  • Track daily MED using an online dosing calculator
  • Use the state Prescription Drug Monitoring Program to monitor all sources of controlled substances

Neurology, 2014; 83; 1277-1284, September 2014

Use of a state PDMP may help identify patients who are at high risk for diversion or doctor shopping… To quantify the effects of PDMPs, studies were conducted of ED providers who cared for adult patients with pain. Of the patients with complete data in one study, information from the state’s PDMP System altered prescribing practice in 41%.

ACEP - Annals of Emergency Medicine - 525

David is Prescription Advisory’s Chief Marketing Officer. Software startups are his passion.

He also serves as the Director of Startup Grind Princeton and a mentor for the Princeton University eLab.

Prescription Advisory Systems & Technology

Request a PastRx Demo

We will contact you to arrange a demo at your convenience.

You have Successfully Subscribed!

Prescription Advisory Systems & Technology

Contact PastRx

A representive will be in touch to answer any questions or concerns you might have.

Thank you! A Prescription Advisory representative will contact you shortly.

Share This